| Year |
Citation |
Score |
| 2024 |
Butler DA, Patel N, O'Donnell JN, Lodise TP. Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature. The Journal of Antimicrobial Chemotherapy. PMID 39215642 DOI: 10.1093/jac/dkae253 |
0.559 |
|
| 2022 |
On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, et al. Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. British Journal of Haematology. PMID 35174480 DOI: 10.1111/bjh.18051 |
0.319 |
|
| 2021 |
Lodise T, Rodriguez M, Chitra S, Wright K, Patel N. Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective. Antibiotics (Basel, Switzerland). 10. PMID 34680776 DOI: 10.3390/antibiotics10101195 |
0.525 |
|
| 2021 |
Lodise TP, Henriksen AS, Hadley T, Patel N. US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales. Open Forum Infectious Diseases. 8: ofab380. PMID 34660834 DOI: 10.1093/ofid/ofab380 |
0.464 |
|
| 2021 |
Patel N, Lowry C, Morgenson D, Shah V, Stornelli N, Lodise TP. Comparative Effectiveness of Early-Targeted Use of Fidaxomicin versus Oral Vancomycin among Hospitalized Veterans' Affairs Patients with Infections due to Clostridioides difficile. Pharmacotherapy. PMID 33455007 DOI: 10.1002/phar.2503 |
0.526 |
|
| 2020 |
Cooksey GE, Epps JL, Moye RA, Patel N, Shorman MA, Veve MP. Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis. The Journal of Infectious Diseases. 222: S506-S512. PMID 32877564 DOI: 10.1093/Infdis/Jiaa055 |
0.364 |
|
| 2020 |
Patel N, Stornelli N, Sangiovanni RJ, Huang DB, Lodise TP. Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions Among Hospitalized Veterans' Affairs Patients with Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. PMID 32718970 DOI: 10.1128/Aac.01268-20 |
0.54 |
|
| 2020 |
Maskarinec SA, Park LP, Ruffin F, Turner NA, Patel N, Eichenberger EM, van Duin D, Lodise T, Fowler VG, Thaden JT. Positive follow-up blood cultures identify high mortality risk Among patients with gram negative bacteremia. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 32114010 DOI: 10.1016/J.Cmi.2020.01.025 |
0.529 |
|
| 2019 |
Ahmed A, Schriever C, Britt N, Yager J, Amin R, McGuey L, Patel N. Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. Annals of Hepatology. PMID 31078440 DOI: 10.1016/J.Aohep.2019.01.005 |
0.353 |
|
| 2019 |
Sangiovanni RJ, Jakeman B, Nasiri M, Ruth L, Mahatme S, Patel N. Relationship between Contraindicated Drug-Drug Interactions and Subsequent Hospitalizations among Patients Living with HIV Initiating Combination Antiretroviral Therapy. Aids Research and Human Retroviruses. PMID 30612438 DOI: 10.1089/Aid.2018.0205 |
0.382 |
|
| 2018 |
Patel N, Huang D, Lodise T. Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Clinical Drug Investigation. PMID 30105549 DOI: 10.1007/S40261-018-0686-5 |
0.526 |
|
| 2018 |
Bidell MR, Patel N, O'Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. The Journal of Antimicrobial Chemotherapy. PMID 30085140 DOI: 10.1093/Jac/Dky259 |
0.319 |
|
| 2018 |
Patel N, Borg P, Haubrich R, McNicholl I. Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 29903710 DOI: 10.2146/Ajhp170613 |
0.349 |
|
| 2018 |
Terloyeva D, Nugmanova Z, Akhmetova G, Akanov A, Patel N, Lazariu V, Norelli L, McNutt LA. Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study. Plos One. 13: e0193976. PMID 29590151 DOI: 10.1371/Journal.Pone.0193976 |
0.542 |
|
| 2018 |
Landry S, Chen CN, Patel N, Tseng A, Lalonde RG, Thibeault D, Sanche S, Sheehan NL. Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series. Antiviral Research. PMID 29458132 DOI: 10.1016/J.Antiviral.2018.02.010 |
0.401 |
|
| 2018 |
Patel N, Clark J, Stornelli N, Belfiore G, Lodise TP. 1463. Comparative Evaluation of Adverse Tendon Events Between Recipients of Fluoroquinolones and Ceftriaxone/Azithromycin Among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia Open Forum Infectious Diseases. 5: S452-S453. DOI: 10.1093/Ofid/Ofy210.1293 |
0.529 |
|
| 2017 |
Britt NS, Potter EM, McKinnell JA, Patel N, Battersby SE, Steed ME. Secular Trends in Nosocomial Vancomycin-Resistant Enterococcal Bloodstream Infections Among United States Veterans Affairs Hospitals, Fiscal Years 2004 through 2014. Infection Control and Hospital Epidemiology. 1-3. PMID 28693646 DOI: 10.1017/Ice.2017.125 |
0.333 |
|
| 2017 |
Jakeman B, Nasiri M, Ruth L, Morse C, Mahatme S, Patel N. Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients. The Annals of Pharmacotherapy. 51: 365-372. PMID 28367698 DOI: 10.1177/1060028016685115 |
0.375 |
|
| 2017 |
Britt NS, Potter EM, Patel N, Steed ME. Effect of Continuous and Sequential Therapy Among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Antimicrobial Agents and Chemotherapy. PMID 28264856 DOI: 10.1128/Aac.02216-16 |
0.423 |
|
| 2017 |
Britt NS, Patel N, Potter EM, Steed ME. Changing Epidemiology of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in United States Veterans Affairs Hospitals, 2004–2014 Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.213 |
0.331 |
|
| 2017 |
Patel N, Clark J, Murray J, Bowles J, Lodise TP. Incidence and Predictors of Fluoroquinolone-Associated Adverse Tendon Events among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia Open Forum Infectious Diseases. 4: S584-S584. DOI: 10.1093/Ofid/Ofx163.1528 |
0.536 |
|
| 2017 |
Britt NS, Patel N, Potter EM, Steed ME. Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection: A National Cohort Study Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.1479 |
0.38 |
|
| 2016 |
Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28011602 DOI: 10.1093/Cid/Ciw815 |
0.398 |
|
| 2016 |
Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. The Journal of Antimicrobial Chemotherapy. PMID 27999028 DOI: 10.1093/Jac/Dkw453 |
0.319 |
|
| 2016 |
Bidell MR, McLaughlin M, Faragon J, Morse C, Patel N. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infectious Diseases and Therapy. PMID 27384319 DOI: 10.1007/S40121-016-0118-X |
0.357 |
|
| 2016 |
Britt NS, Patel N, Horvat RT, Steed ME. Vancomycin 24-hour area under the curve (AUC24)/minimum bactericidal concentration (MBC) ratio as a novel predictor of mortality in methicillin-resistant Staphylococcus aureus bacteremia (MRSA-B). Antimicrobial Agents and Chemotherapy. PMID 26953202 DOI: 10.1128/Aac.02714-15 |
0.373 |
|
| 2016 |
Schriever C, Ahmed A, Delehanty K, Yager J, Farrow G, Kashtan R, Lodise T, Patel N. Comparison of Frequencies of Drug-Drug Interactions between Sofosbuvir/Ledipasvir and Ombitasvir/Dasabuvir/Paritaprevir/Ritonavir +/− Ribavirin among HIV/HCV Coinfected Patients Journal of Hepatology. 64: S801. DOI: 10.1016/S0168-8278(16)01563-4 |
0.477 |
|
| 2015 |
Nugmanova Z, Patel N, Akhmetova GM, Kurmangalieva GS, Abdumananova MK, Akanov AA, Kovtunenko NG, McNutt LA. Relationship between vitamin D and human immunodeficiency virus (HIV) viral load among HIV-infected patients in Kazakhstan. Journal of Infection in Developing Countries. 9: 1277-83. PMID 26623638 DOI: 10.3855/Jidc.6808 |
0.556 |
|
| 2015 |
Patel N, Assimon MM, Bruni E, McNutt LA, Mason DL. Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity. Southern Medical Journal. 108: 567-73. PMID 26332483 DOI: 10.14423/Smj.0000000000000343 |
0.541 |
|
| 2015 |
Britt NS, Potter EM, Patel N, Steed ME. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26063715 DOI: 10.1093/Cid/Civ444 |
0.36 |
|
| 2015 |
Patel N, Nasiri M, Koroglu A, Bliss S, Davis M, McNutt LA, Miller C. A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients. Infectious Diseases and Therapy. PMID 25708155 DOI: 10.1007/S40121-015-0058-X |
0.614 |
|
| 2015 |
Nugmanova Z, Patel N, Nurbakhyt A, Akhmetova GM, Kovtunenko N, Trumova Z, McNutt LA. Universal precautions in Central Asia: the need for multiple strategies in this window of opportunity. The Journal of Hospital Infection. 89: 197-201. PMID 25623208 DOI: 10.1016/j.jhin.2014.11.011 |
0.495 |
|
| 2015 |
Patel N, Nasiri M, Koroglu A, Amin R, McGuey L, McNutt LA, Roman M, Miller C. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection. Aids Research and Human Retroviruses. 31: 189-97. PMID 25432275 DOI: 10.1089/Aid.2014.0215 |
0.626 |
|
| 2014 |
Patel N, Veve M, Bliss S, Nasiri M, McNutt LA, Lazariu V, Roman M, Miller C. Prevalence and Predictors of Important Telaprevir Drug Interactions Among Patients Coinfected With Hepatitis C and Human Immunodeficiency Virus. The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians. 30: 159-167. PMID 34860905 DOI: 10.1177/8755122514533941 |
0.592 |
|
| 2014 |
McConnell HL, Perris ET, Lowry C, Lodise T, Patel N. Effect of Concomitant 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor Therapy on Creatine Phosphokinase Levels and Mortality Among Patients Receiving Daptomycin: Retrospective Cohort Study. Infectious Diseases and Therapy. PMID 25245515 DOI: 10.1007/S40121-014-0041-Y |
0.541 |
|
| 2014 |
Patel N, Veve M, Nasiri M, Bliss S, McNutt LA, Lazariu V, Miller C. Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis C therapy among patients coinfected with hepatitis C and HIV. Aids Patient Care and Stds. 28: 513-6. PMID 25093994 DOI: 10.1089/Apc.2014.0149 |
0.629 |
|
| 2014 |
Patel N, Veve M, Bliss S, Nasiri M, Mcnutt LA, Lazariu V, Roman M, Miller C. Prevalence and predictors of important telaprevir drug interactions among patients coinfected with hepatitis C and human immunodeficiency virus Journal of Pharmacy Technology. 30: 159-167. DOI: 10.1177/8755122514533941 |
0.626 |
|
| 2013 |
Lodise TP, Patel N, Rivera A, Tristani L, Lazariu V, Vandewall H, McNutt LA. Comparative evaluation of serotonin toxicity among veterans affairs patients receiving linezolid and vancomycin. Antimicrobial Agents and Chemotherapy. 57: 5901-11. PMID 24041888 DOI: 10.1128/Aac.00921-13 |
0.687 |
|
| 2013 |
Casapao AM, Leonard SN, Davis SL, Lodise TP, Patel N, Goff DA, Laplante KL, Potoski BA, Rybak MJ. Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bloodstream infection. Antimicrobial Agents and Chemotherapy. PMID 23796929 DOI: 10.1128/Aac.00380-13 |
0.589 |
|
| 2013 |
Patel N, Veve M, Kwon S, McNutt LA, Fish D, Miller CD. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation. Hiv Medicine. 14: 463-71. PMID 23506263 DOI: 10.1111/hiv.12031 |
0.594 |
|
| 2013 |
Butterfield JM, Mueller BA, Patel N, Cardone KE, Grabe DW, Salama NN, Lodise TP. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis Antimicrobial Agents and Chemotherapy. 57: 864-872. PMID 23208714 DOI: 10.1128/Aac.02000-12 |
0.544 |
|
| 2012 |
Patel N, Miller CD. New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir. Hiv/Aids (Auckland, N.Z.). 4: 61-71. PMID 22570576 DOI: 10.2147/Hiv.S25149 |
0.399 |
|
| 2012 |
Patel N, VanDeWall H, Tristani L, Rivera A, Woo B, Dihmess A, Li HK, Smith R, Lodise TP. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin. The Journal of Antimicrobial Chemotherapy. 67: 727-35. PMID 22174041 DOI: 10.1093/Jac/Dkr522 |
0.546 |
|
| 2011 |
Butterfield JM, Patel N, Pai MP, Rosano TG, Drusano GL, Lodise TP. Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding. Antimicrobial Agents and Chemotherapy. 55: 4277-82. PMID 21670191 DOI: 10.1128/Aac.01674-10 |
0.501 |
|
| 2011 |
Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, Lodise TP. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. The Journal of Antimicrobial Chemotherapy. 66: 1600-8. PMID 21508008 DOI: 10.1093/Jac/Dkr156 |
0.695 |
|
| 2011 |
Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: we can't get there from here. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 969-74. PMID 21460308 DOI: 10.1093/Cid/Cir078 |
0.518 |
|
| 2011 |
Cardone KE, Lodise TP, Patel N, Hoy CD, Meola S, Manley HJ, Drusano GL, Grabe DW. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 1081-8. PMID 21393490 DOI: 10.2215/Cjn.08510910 |
0.534 |
|
| 2011 |
Patel N, Abdelsayed S, Veve M, Miller CD. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. The Annals of Pharmacotherapy. 45: 317-24. PMID 21386025 DOI: 10.1345/Aph.1P576 |
0.386 |
|
| 2011 |
Miller CD, Crain J, Tran B, Patel N. Rilpivirine: a new addition to the anti-HIV-1 armamentarium. Drugs of Today (Barcelona, Spain : 1998). 47: 5-15. PMID 21373646 DOI: 10.1358/Dot.2011.47.1.1583188 |
0.409 |
|
| 2011 |
Patel N, Cardone K, Grabe DW, Meola S, Hoy C, Manley H, Drusano GL, Lodise TP. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis. Antimicrobial Agents and Chemotherapy. 55: 1677-83. PMID 21282429 DOI: 10.1128/Aac.01224-10 |
0.538 |
|
| 2010 |
Patel N, Scheetz MH, Drusano GL, Lodise TP. Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success. The Journal of Antimicrobial Chemotherapy. 65: 2285-90. PMID 20736235 DOI: 10.1093/Jac/Dkq323 |
0.524 |
|
| 2010 |
Adams J, Patel N, Mankaryous N, Tadros M, Miller CD. Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents. The Annals of Pharmacotherapy. 44: 157-65. PMID 19996323 DOI: 10.1345/Aph.1M359 |
0.395 |
|
| 2010 |
Patel N, Scheetz MH, Drusano GL, Lodise TP. Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients Antimicrobial Agents and Chemotherapy. 54: 460-465. PMID 19858253 DOI: 10.1128/Aac.00296-09 |
0.531 |
|
| 2009 |
Patel N, Lubanski P, Ferro S, Bonafede M, Harrington S, Evans A, Stellrecht K, Lodise TP. Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy. 53: 5141-5144. PMID 19805558 DOI: 10.1128/Aac.00307-09 |
0.558 |
|
| 2009 |
Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 507-14. PMID 19586413 DOI: 10.1086/600884 |
0.594 |
|
| 2009 |
Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, Patel N. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. American Journal of Therapeutics. 16: 508-11. PMID 19531934 DOI: 10.1097/Mjt.0B013E3181A1Afb7 |
0.584 |
|
| 2009 |
Patel GW, Patel N, Lat A, Trombley K, Enbawe S, Manor K, Smith R, Lodise TP. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagnostic Microbiology and Infectious Disease. 64: 236-40. PMID 19500529 DOI: 10.1016/J.Diagmicrobio.2009.03.002 |
0.561 |
|
| 2008 |
Patel N, McNutt LA, Lodise TP. Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 52: 2933-6. PMID 18519718 DOI: 10.1128/Aac.00456-08 |
0.678 |
|
| 2008 |
Lodise TP, Patel N, Renaud-Mutart A, Gorodecky E, Fritsche TR, Jones RN. Pharmacokinetic and pharmacodynamic profile of ceftobiprole. Diagnostic Microbiology and Infectious Disease. 61: 96-102. PMID 18384996 DOI: 10.1016/J.Diagmicrobio.2008.02.013 |
0.556 |
|
| 2007 |
Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrobial Agents and Chemotherapy. 51: 3510-5. PMID 17646415 DOI: 10.1128/Aac.00338-07 |
0.576 |
|
| 2007 |
Lodise TP, Miller C, Patel N, Graves J, McNutt LA. Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates. Infection Control and Hospital Epidemiology. 28: 959-65. PMID 17620244 DOI: 10.1086/518972 |
0.706 |
|
| Show low-probability matches. |